Form 13F security
IMVT · IMMUNOVANT INC
Class COM
As filed on Form 13F — long US-listed positions only. No shorts, cash, bonds, or non-13F assets appear here.
Filed up to 45 days after quarter end; holdings may have changed since.
Tracked managers holding it
Share and principal positions
| Manager | Quarter | Value | % of portfolio | SH/PRN qty | Put/call |
|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 2026-06-30 | $224M | 1.0% | SH 5,805,000 | — |
| DME Capital Management, LP — David Einhorn — Greenlight | 2026-06-30 | $3.6M | <0.1% | SH 93,520 | — |
Total $227M across 2 of 69 managers.
Sums are across tracked reports, not unique economic ownership.
DME Capital Management, LP — Combined report.
Filed rows (3) — as filed
The filer reports some securities in multiple rows; rows are shown as filed.
| Manager | Class | Put/call | Value | % of portfolio | SH/PRN qty | Source |
|---|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT, L.L.C. | COM | — | $224M | 1.0% | SH 5,805,000 | 0000908834-26-000432 |
| DME Capital Management, LP | COM | — | $3.0M | <0.1% | SH 78,610 | 0001172661-26-003786 |
| DME Capital Management, LP | COM | — | $0.6M | <0.1% | SH 14,910 | 0001172661-26-003786 |
Quarter-to-quarter notes
Reported change, not a confirmed trade: this compares quarter-end reports filed up to 45 days later, and the position may since have changed. Amendments, corporate actions, and changes in reporting scope can also move these rows. Value change compares period-end reported values; for continuing rows it includes market price movement.
—
Changes appear only where the prior quarter's validated report exists.